Antidrug Antibodies in Patients Treated with Alirocumab
| Errataetall: |
CommentOn: N Engl J Med. 2017 Apr 20;376(16):1517-1526. - PMID 28304227 |
|---|---|
| Medienart: |
E-Artikel |
| Erscheinungsjahr: |
2017 |
|---|---|
| Erschienen: |
2017 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:376 |
|---|---|
| Enthalten in: |
The New England journal of medicine - 376(2017), 16 vom: 20. Apr., Seite 1589-90 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Roth, Eli M [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antibodies |
|---|
| Anmerkungen: |
Date Completed 21.04.2017 Date Revised 02.12.2018 published: Print-Electronic CommentOn: N Engl J Med. 2017 Apr 20;376(16):1517-1526. - PMID 28304227 Citation Status MEDLINE |
|---|
| doi: |
10.1056/NEJMc1616623 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM269941274 |
|---|
| LEADER | 01000naa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM269941274 | ||
| 003 | DE-627 | ||
| 005 | 20231224225523.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231224s2017 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1056/NEJMc1616623 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n0899.xml |
| 035 | |a (DE-627)NLM269941274 | ||
| 035 | |a (NLM)28304229 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Roth, Eli M |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Antidrug Antibodies in Patients Treated with Alirocumab |
| 264 | 1 | |c 2017 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 21.04.2017 | ||
| 500 | |a Date Revised 02.12.2018 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a CommentOn: N Engl J Med. 2017 Apr 20;376(16):1517-1526. - PMID 28304227 | ||
| 500 | |a Citation Status MEDLINE | ||
| 650 | 4 | |a Letter | |
| 650 | 4 | |a Comment | |
| 650 | 7 | |a Antibodies |2 NLM | |
| 650 | 7 | |a Antibodies, Monoclonal |2 NLM | |
| 650 | 7 | |a Anticholesteremic Agents |2 NLM | |
| 700 | 1 | |a Goldberg, Anne C |e verfasserin |4 aut | |
| 700 | 1 | |a Catapano, Alberico L |e verfasserin |4 aut | |
| 700 | 1 | |a Torri, Albert |e verfasserin |4 aut | |
| 700 | 1 | |a Yancopoulos, George D |e verfasserin |4 aut | |
| 700 | 1 | |a Stahl, Neil |e verfasserin |4 aut | |
| 700 | 1 | |a Brunet, Aurélie |e verfasserin |4 aut | |
| 700 | 1 | |a Lecorps, Guillaume |e verfasserin |4 aut | |
| 700 | 1 | |a Colhoun, Helen M |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t The New England journal of medicine |d 1945 |g 376(2017), 16 vom: 20. Apr., Seite 1589-90 |w (DE-627)NLM000008184 |x 1533-4406 |7 nnns |
| 773 | 1 | 8 | |g volume:376 |g year:2017 |g number:16 |g day:20 |g month:04 |g pages:1589-90 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1056/NEJMc1616623 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 376 |j 2017 |e 16 |b 20 |c 04 |h 1589-90 | ||